Terms: = Liver cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
34 results:
1. Triple Primary cancers: An Analysis of Genetic and Environmental Factors.
Borja NA; Silva-Smith R; Calfa C; Sussman DA; Tekin M
Cancer Prev Res (Phila); 2024 May; 17(5):209-215. PubMed ID: 38361103
[TBL] [Abstract] [Full Text] [Related]
2. Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma.
Du J; Huang Z; Zhang E
Front Immunol; 2024; 15():1329634. PubMed ID: 38304429
[TBL] [Abstract] [Full Text] [Related]
3. Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation.
Zhang S; Shi YN; Gu J; He P; Ai QD; Zhou XD; Wang W; Qin L
Pharm Biol; 2023 Dec; 61(1):1108-1119. PubMed ID: 37462387
[TBL] [Abstract] [Full Text] [Related]
4. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Dumago MP; Agas RAF; Jainar CJE; Yap ET; Co LBA; Ortin TTS
J Gastrointest Cancer; 2023 Dec; 54(4):1058-1070. PubMed ID: 37306936
[TBL] [Abstract] [Full Text] [Related]
5. Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators.
Yu X; Yang R; He Z; Zeng P
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8969-8979. PubMed ID: 37160627
[TBL] [Abstract] [Full Text] [Related]
6. [The expression and function of PD-L1 in CD133(+) human liver cancer stem-like cells].
Bai YD; Shi ML; Li SQ; Wang XL; Peng JJ; Zhou DJ; Sun FF; Li H; Wang C; Du M; Zhang T; Li D
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):117-128. PubMed ID: 36781232
[No Abstract] [Full Text] [Related]
7. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
[TBL] [Abstract] [Full Text] [Related]
8. Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI.
Qiong L; Jie Z; Zhong Z; Wen S; Jun Z; Liping L; Jinkui C
BMJ Open; 2022 Feb; 12(2):e058461. PubMed ID: 35177466
[TBL] [Abstract] [Full Text] [Related]
9. Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B.
Jeong S; Shin HP; Kim HI
Intervirology; 2022; 65(2):94-103. PubMed ID: 34731856
[TBL] [Abstract] [Full Text] [Related]
10. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
Toy M; Hutton D; Harris AM; Nelson N; Salomon JA; So S
Clin Infect Dis; 2022 Jan; 74(2):210-217. PubMed ID: 33956937
[TBL] [Abstract] [Full Text] [Related]
11. Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
Yuan G; Song Y; Li Q; Hu X; Zang M; Dai W; Cheng X; Huang W; Yu W; Chen M; Guo Y; Zhang Q; Chen J
Front Immunol; 2020; 11():613946. PubMed ID: 33488622
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Factors After Surgical treatment of liver Metastases from Breast cancer - 19 Years of Experience.
ProchÁzkovÁ K; PivovarČÍkovÁ K; RouŠarovÁ M; VodiČka J; HoŠek P; TŘeŠkovÁ I; Hes O; KuČera R; TopolČan O; TŘeŠka V
In Vivo; 2021; 35(1):417-422. PubMed ID: 33402491
[TBL] [Abstract] [Full Text] [Related]
13. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
[TBL] [Abstract] [Full Text] [Related]
14. Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan.
Hu TH; Yueh-Hsia Chiu S; Tseng PL; Chen CH; Lu SN; Wang JH; Hung CH; Kee KM; Lin MT; Chang KC; Lin MC; Chien RN
Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1695-1706. PubMed ID: 33111400
[TBL] [Abstract] [Full Text] [Related]
15. Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
Shin JW; Jeong J; Jung SW; Lee SB; Park BR; Kim MJ; Park EJ; Park NH
Dig Dis Sci; 2021 May; 66(5):1739-1750. PubMed ID: 32524416
[TBL] [Abstract] [Full Text] [Related]
16. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
[TBL] [Abstract] [Full Text] [Related]
17. Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir.
Lee SB; Jeong J; Park JH; Jung SW; Jeong ID; Bang SJ; Shin JW; Park BR; Park EJ; Park NH
Clin Mol Hepatol; 2020 Jul; 26(3):364-375. PubMed ID: 32466635
[TBL] [Abstract] [Full Text] [Related]
18. Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib treatment for Unresectable Hepatocellular Carcinoma.
Hiraoka A; Kumada T; Tada T; Fukunishi S; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Kawata K; Toyoda H; Ohama H; Tsutsui A; Itokawa N; Hayama K; Arai T; Imai M; Nakamura S; Michitaka K; Hiasa Y; Kudo M;
Oncology; 2020; 98(5):295-302. PubMed ID: 32097925
[TBL] [Abstract] [Full Text] [Related]
19. Thalidomide Combined with Transcatheter Arterial Chemoembolization (TACE) for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and GRADE Approach.
Yang W; Wang D; Huang L; Chen Y; Wen S; Hong Q; Kang D
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2043-2055. PubMed ID: 30139041
[TBL] [Abstract] [Full Text] [Related]
20. The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B.
Kim BG; Park NH; Lee SB; Jeon S; Park JH; Jung SW; Jeong ID; Bang SJ; Shin JW
Liver Int; 2018 Dec; 38(12):2269-2276. PubMed ID: 30052303
[TBL] [Abstract] [Full Text] [Related]
[Next]
